Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

RESILIENCE-BUILDING INTERVENTION for EMERGENCY NURSES IN PALESTINIAN HOSPITALS (RBI-ENPH)

15. juli 2026 oppdatert av: Saqr Alkorom, Nablus University for Vocational and Technical Education

The Effect of a Resilience-Building Intervention on Psychological Well-Being and Advanced Life Support Performance Among Emergency Nurses in Palestinian Hospitals: A Quasi-Experimental Study

The goal of this quasi-experimental clinical trial is to evaluate the effect of a culturally adapted, six-week resilience-building programme on psychological well-being and clinical performance in emergency nurses working in Palestinian hospitals. The main questions it aims to answer are:

Does the six-week resilience-building programme improve the psychological well-being of emergency nurses? Does the intervention enhance their Advanced Life Support (ALS) performance during a simulation-based assessment? Researchers will compare the intervention group receiving the resilience-building programme to a non-equivalent control group to see if the intervention leads to significant improvements in adaptive coping, mental health, and simulated clinical performance.

Participants will:

Participate in a six-week resilience-building programme integrating cognitive-behavioural techniques, mindfulness, stress inoculation training, and mental rehearsal (intervention group only).

Complete validated questionnaires to measure psychological well-being and resilience before and after the study period.

Complete a standardized, high-fidelity simulated scenario to assess their Advanced Life Support (ALS) clinical performance.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

Emergency nurses in Palestine operate under severe clinical and contextual stressors, including prolonged political conflict, acute resource shortages, and high patient acuity. Chronic exposure to these multifaceted stressors often leads to elevated psychological distress, which not only impacts the nurses' mental health but also has the potential to impair their clinical performance in high-stakes, life-saving situations. Addressing both psychological well-being and clinical competence is critical in this high-pressure environment.

Guided by Roy's Adaptation Model, this research addresses a critical gap in the literature by evaluating a dual-outcome intervention. The study hypothesizes that by enhancing adaptive coping mechanisms, nurses will not only improve their personal psychological resilience but also maintain or improve their objective clinical performance under stress.

To achieve this, the study utilizes a quasi-experimental, non-equivalent control group pre-test/post-test design. To prevent treatment contamination between groups, allocation to either the intervention or control group is conducted at the hospital level.

The intervention consists of a culturally adapted, six-week resilience-building programme. It is specifically designed for the Palestinian context and integrates elements of cognitive-behavioural techniques, mindfulness, stress inoculation training, and mental rehearsal. The study will evaluate the programme's effectiveness by assessing changes in psychological well-being and objective clinical performance (specifically, Advanced Life Support [ALS] skills) before and after the study period. By utilizing high-fidelity simulated scenarios alongside validated psychometric tools, this study aims to provide robust, evidence-based recommendations for integrating psychological resilience training into clinical performance frameworks and nursing education.

Studietype

Intervensjonell

Registrering (Antatt)

140

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

Registered nurses currently employed in the Emergency Department of the selected Palestinian hospitals.

Nurses working full-time Willingness to commit to the 6-week intervention program and complete all simulation-based assessments.

Provided written informed consent to participate in the study.

Exclusion Criteria:

  • Nurses who have participated in formal resilience or stress management training programs within the past year.

Nurses currently receiving medical or psychological treatment for diagnosed mental health conditions.

Nurses with physical or medical conditions that prohibit them from performing Advanced Life Support (ALS) chest compressions during the simulation assessment.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Resilience-Building Programme
Participants in this arm will receive the culturally adapted, six-week resilience-building programme.
A six-week programme integrating cognitive-behavioural techniques, mindfulness, stress inoculation training, and mental rehearsal. The programme is specifically adapted for the Palestinian emergency nursing context to enhance adaptive coping mechanisms and psychological well-being.
Ingen inngripen: Standard Practice
Participants in this arm will not receive the resilience-building programme and will continue with their standard practice

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Psychological well-being and resilience score
Tidsramme: Baseline and Week 6
Psychological resilience is measured using the Connor-Davidson Resilience Scale (CD-RISC-10). The scale consists of 10 items. The total score is calculated by summing all item scores. The total score ranges from a minimum of 0 to a maximum of 40. Higher scores indicate greater psychological resilience and better adaptive coping.
Baseline and Week 6
Advanced Life Support (ALS) Clinical Performance Percentage
Tidsramme: Baseline and Week 6
Clinical performance is assessed during a simulated Pulseless Ventricular Tachycardia scenario using the CPR Performance Assessment Checklist Based on AHA Guidelines. The assessment evaluates 15 critical actions. The total score is calculated as a percentage, ranging from 0% to 100%. Higher scores indicate better clinical performance and adherence to standard protocols, with scores of 90% or above categorized as "Excellent
Baseline and Week 6

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Psychological Distress (Depression, Anxiety, and Stress) Scores
Tidsramme: Baseline and Week 6
Psychological distress is measured using the Depression, Anxiety and Stress Scale (DASS-21). The scale evaluates three subscales: Depression (7 items), Anxiety (7 items), and Stress (7 items). The score for each subscale is calculated by summing the specific items and multiplying the sum by 2. Each of the three subscale scores ranges from a minimum of 0 to a maximum of 42. Higher scores indicate greater levels of depression, anxiety, and stress, reflecting poorer psychological well-being.
Baseline and Week 6

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. juli 2026

Primær fullføring (Antatt)

1. oktober 2026

Studiet fullført (Antatt)

1. oktober 2026

Datoer for studieregistrering

Først innsendt

9. juli 2026

Først innsendt som oppfylte QC-kriteriene

9. juli 2026

Først lagt ut (Faktiske)

14. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2026421-16646

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere